KUALA LUMPUR: The Health Ministry has agreed to grant conditional registration approval for the product Evusheld 100 milligrammes per millimetre (mg/ml) Solution For Injection (Tixagevimab 100 mg/ml and Cilgavimab 100 mg/ml) manufactured by Astrazeneca AB of Sweden.
The children will receive a dose of 10 micrograms (mcg) Concentration for Dispersion for Injection, compared to the 30 mcg dose of Comirnaty (Tris/Sucrose) that adolescents receive, Health Minister Khairy Jamaluddin said.
The Ministry of Health (MOH) has prepared the standard operating procedures (SOPs) for the Melaka election and is ready to discuss with the Election Commission (EC) if the polls is given the go ahead